Drug Approval Package
-
Noxafil (posaconazole) Oral Suspension
Company: Schering Corporation
NDA: 22027
Approval Date: 10/20/2006
- Approval Letter(s) (PDF)
- Printed Labeling (PDF)
- Medical Review(s)
- Chemistry Review(s) (PDF)
- Pharmacology Review(s) (PDF)
- Statistical Review(s) (PDF)
- Microbiology Review(s) (PDF)
- Clinical Pharmacology Biopharmaceutics Review(s) (PDF)
- Administrative Document(s) and Correspondence (PDF)
Date created: September 5, 2008
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-